111 related articles for article (PubMed ID: 17637307)
1. [The prognostic significance of derivative chromosome 9 deletions in chronic myeloid leukemia].
Wu W; Li JY; Shen YF; Cao XS; Qiu HR; Xu W
Zhonghua Nei Ke Za Zhi; 2007 May; 46(5):386-8. PubMed ID: 17637307
[TBL] [Abstract][Full Text] [Related]
2. The negative prognostic impact of derivative 9 deletions in patients who received hydroxyurea treatment for chronic myelogenous leukemia in the chronic phase.
Li JY; Xu W; Wu W; Zhu Y; Qiu HR; Zhang R; Zhang SJ; Qian SX
Onkologie; 2008 Nov; 31(11):585-9. PubMed ID: 19145090
[TBL] [Abstract][Full Text] [Related]
3. A study on the incidence of ABL gene deletion on derivative chromosome 9 in chronic myelogenous leukemia by interphase fluorescence in situ hybridization and its association with disease progression.
Lee DS; Lee YS; Yun YS; Kim YR; Jeong SS; Lee YK; She CJ; Yoon SS; Shin HR; Kim Y; Cho HI
Genes Chromosomes Cancer; 2003 Jul; 37(3):291-9. PubMed ID: 12759927
[TBL] [Abstract][Full Text] [Related]
4. [Deletions of derivative chromosome 9 in 138 patients with chronic myeloid leukemia].
Wang L; Qian SX; Qiu HR; Wang R; Zhang SJ; Miao KR; Fan L; Xu W; Li JY
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2009 Apr; 17(2):281-4. PubMed ID: 19379551
[TBL] [Abstract][Full Text] [Related]
5. [Study of deletion of derivative chromosome 9 in patients with Ph+ chronic myeloid leukemia].
Wu W; Xue YQ; Wu YF; Pan JL; Shen J
Zhonghua Xue Ye Xue Za Zhi; 2006 Mar; 27(3):183-6. PubMed ID: 16792921
[TBL] [Abstract][Full Text] [Related]
6. Interphase fluorescence in situ hybridization studies for the detection of 9q34 deletions in chronic myelogenous leukemia: a practical approach to clinical diagnosis.
Aoun P; Wiggins M; Pickering D; Foran J; Rasheed H; Pavletic SZ; Sanger W
Cancer Genet Cytogenet; 2004 Oct; 154(2):138-43. PubMed ID: 15474149
[TBL] [Abstract][Full Text] [Related]
7. No significance of derivative chromosome 9 deletion on the clearance kinetics of BCR/ABL fusion transcripts, cytogenetic or molecular response, loss of response, or treatment failure to imatinib mesylate therapy for chronic myeloid leukemia.
Kim DH; Popradi G; Sriharsha L; Kamel-Reid S; Chang H; Messner HA; Lipton JH
Cancer; 2008 Aug; 113(4):772-81. PubMed ID: 18543309
[TBL] [Abstract][Full Text] [Related]
8. [Molecular genetics in chronic myeloid leukemia with variant Ph translocation].
Wu W; Li JY; Zhu Y; Qiu HR; Pan JL; Xu W; Chen LJ; Shen YF; Xue YQ
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2007 Aug; 24(4):470-3. PubMed ID: 17680547
[TBL] [Abstract][Full Text] [Related]
9. Prognostic Implications of Derivative Chromosome 9 Deletions in Patients with Advanced-Stage Chronic Myelogenous Leukemia.
Chandran RK; Geetha N; Sakthivel KM; Aswathy CG; Gopinath P; Nair JKKM; Sreedharan H
J Environ Pathol Toxicol Oncol; 2018; 37(2):117-126. PubMed ID: 30055547
[TBL] [Abstract][Full Text] [Related]
10. [Detection of bcr/abl fusion gene and its derivative chromosome 9 deletions in CML by using home-made bcr/abl extra-signal probe].
Lai YY; Feng L; Wang Z; Lü S; Dang H; Shi Y; He Q; Huang XJ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2010 Feb; 18(1):199-203. PubMed ID: 20137147
[TBL] [Abstract][Full Text] [Related]
11. Coexistence of Philadelphia chromosome positive cells with and without der(9) deletion in a patient with chronic myelogenous leukemia.
Xinh PT; Vu HA; Nghia H; Binh NT; Van Be T; Van Binh T; Tokunaga K; Sato Y
Cancer Genet Cytogenet; 2006 Jan; 164(2):122-7. PubMed ID: 16434314
[TBL] [Abstract][Full Text] [Related]
12. Deletion of any part of the BCR or ABL gene on the derivative chromosome 9 is a poor prognostic marker in chronic myelogenous leukemia.
Lee YK; Kim YR; Min HC; Oh BR; Kim TY; Kim YS; Cho HI; Kim HC; Lee YS; Lee DS
Cancer Genet Cytogenet; 2006 Apr; 166(1):65-73. PubMed ID: 16616113
[TBL] [Abstract][Full Text] [Related]
13. Deletions on der(9) chromosome in adult Ph-positive acute lymphoblastic leukemia occur with a frequency similar to that observed in chronic myeloid leukemia.
Specchia G; Albano F; Anelli L; Storlazzi CT; Zagaria A; Mancini M; Cuneo A; Pane F; Foà R; Manolelli F; Liso V; Rocchi M
Leukemia; 2003 Mar; 17(3):528-31. PubMed ID: 12646940
[TBL] [Abstract][Full Text] [Related]
14. Deletions of the derivative chromosome 9 do not influence the response and the outcome of chronic myeloid leukemia in early chronic phase treated with imatinib mesylate: GIMEMA CML Working Party analysis.
Castagnetti F; Testoni N; Luatti S; Marzocchi G; Mancini M; Kerim S; Giugliano E; Albano F; Cuneo A; Abruzzese E; Martino B; Palandri F; Amabile M; Iacobucci I; Alimena G; Pane F; Martinelli G; Saglio G; Baccarani M; Rosti G
J Clin Oncol; 2010 Jun; 28(16):2748-54. PubMed ID: 20439635
[TBL] [Abstract][Full Text] [Related]
15. [The application of fluorescence in situ hybridization in detecting chronic myeloid leukemia].
Qiu HR; Miao KR; Wang R; Qiao C; Zhang JF; Zhang SJ; Qian SX; Xu W; Li JY
Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2009 Apr; 26(2):207-10. PubMed ID: 19350518
[TBL] [Abstract][Full Text] [Related]
16. [Karyotype analysis in 119 patients with chronic myeloid leukemia at blast crisis].
Zhu Y; Li JY; Pan JL; Wu W; Qiu HR; Wu YF; Yang H; Zhang JF; Chen LJ; Xue YQ
Zhongguo Shi Yan Xue Ye Xue Za Zhi; 2006 Dec; 14(6):1074-8. PubMed ID: 17204167
[TBL] [Abstract][Full Text] [Related]
17. A pericentric inv(9)(p22q34) of the der(9)t(9;22)(q34;q11.2) is a recurrent secondary anomaly in Ph-positive leukemia.
Pan J; Xue Y; Qiu H; Chen S; Zhang J; Wu Y; Shen J; Wang Y
Cancer Genet Cytogenet; 2010 Dec; 203(2):333-40. PubMed ID: 21156255
[TBL] [Abstract][Full Text] [Related]
18. Evidence for deletion of 9q as a two-step process in chronic myeloid leukemia.
Rudduck-Sivaswaren C; Tien SL; Lim P; Lim E; Lie DK; Tan PH; Lee AS
Clin Genet; 2005 Nov; 68(5):461-5. PubMed ID: 16207215
[TBL] [Abstract][Full Text] [Related]
19. Derivative chromosome 9 deletions are a significant feature of childhood Philadelphia chromosome positive acute lymphoblastic leukaemia.
Robinson HM; Martineau M; Harris RL; Barber KE; Jalali GR; Moorman AV; Strefford JC; Broadfield ZJ; Cheung KL; Harrison CJ
Leukemia; 2005 Apr; 19(4):564-71. PubMed ID: 15716990
[TBL] [Abstract][Full Text] [Related]
20. "Home-brew" FISH assay shows higher efficiency than BCR-ABL dual color, dual fusion probe in detecting microdeletions and complex rearrangements associated with t(9;22) in chronic myeloid leukemia.
Albano F; Anelli L; Zagaria A; Archidiacono N; Liso V; Specchia G; Rocchi M
Cancer Genet Cytogenet; 2007 Apr; 174(2):121-6. PubMed ID: 17452253
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
